Cerebellar Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Alcohol Use Disorder

Completed · Not applicable · Has a placebo group

Conditions studied: Alcohol Use Disorder

In brief

The objective of the current study is to investigate the effects of repetitive transcranial magnetic stimulation (rTMS) on self-reported negative affect, cerebellar brain activation and alcohol use outcomes in alcohol use disorder (AUD).

Key facts

Study ID

NCT03829761

Run by

The Mind Research Network

People needed

24

Starts

2019-02-20

Expected to finish

2023-09-07

Last updated by the study team

2023-10-23

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females age 18-65 meeting DSM-V criteria for moderate or severe AUD in the past year;
• Interested in cutting down or quitting drinking;
• Able to provide voluntary informed consent;
• Have at least 4 heavy drinking days (≥ 5 drinks per day for men, and ≥4 for women) in the past 60 days;
• Currently receiving treatment for alcohol use disorder.

You may not qualify if…

• Severe neurological conditions (TBI/stroke/history of a seizure/dementia and other significant cognitive illnesses);
• Other urgent medical problems, as determined by the study physician from the history and physical exam;
• Schizophrenia, schizoaffective disorder, bipolar I disorder
• Suicidal thoughts (intent or plan) in the last month;
• Current moderate or severe other SUD (except nicotine or marijuana) or other drug (except nicotine or marijuana) use in the past month;
• Active legal problems with the potential to result in incarceration;
• Pregnancy or lactation, or child bearing age and sexually active but not on birth control (barrier methods allowed);
• Current daily use of anti-craving medications, antidepressants (at doses considered therapeutic for depression), benzodiazepines, antipsychotics (at doses considered therapeutic for psychosis or mood stabilization), mood stabilizers (at doses considered therapeutic for mood stabilization);
• Have previously undergone rTMS (to assure the blind is effective);
• Personal or familial (in first degree relatives) history of epilepsy;
• Any contraindication for Magnetic Resonance Imaging (MRI) or TMS including metal shards or certain implants (pacemakers etc.) in the body.

Where it is running

• The Mind Research Network — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.